First-in-human Phase I study of EZN-4176, a locked nucleic acid antisense oligonucleotide to exon 4 of the androgen receptor mRNA in patients with castration-resistant prostate cancer.
| Image |  |
|---|---|
| Description | scientific article published on 29 October 2013 |
| Author/s |
author: Susana Miranda Mateus Crespo David Lorente Dana E. Rathkopf Gerhardt Attard |
| Publication date | October 29, 2013 |
| Language | English |
| Country of origin | |
| Wikipedia link | |
| Copyright status | |
| Missing/wrong data? | Edit Wikidata item |